Related Experiment Video
Updated: Mar 10, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Albuminuria Linked with Interstitial Myocardial Fibrosis At The Population Level: The Multi-Ethnic Study of
Omar Chehab1, Ashkan Abdollahi1, Ralph Zeitoun1
1Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Insights
Elevated albuminuria, a marker for cardiovascular disease, is linked to subclinical myocardial fibrosis in the general population. This association is stronger in men, prediabetics, and diabetics, independent of traditional risk factors.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Albuminuria is a known cardiovascular disease (CVD) marker in diabetic and non-diabetic individuals.
- The relationship between albuminuria and myocardial fibrosis in the general population is not well understood.
Purpose of the Study:
- To investigate the association between albuminuria and subclinical myocardial fibrosis.
- To explore these associations across different sex and diabetes status groups.
Main Methods:
- Utilized data from 2,112 participants in the MESA cohort with urine albumin-creatinine ratio (ACR) and cardiac magnetic resonance (CMR) with T1-mapping.
- Assessed associations between albuminuria/ACR and extracellular volume (ECV), native T1-time, and myocardial scar using multivariable regression models.
Main Results:
- Higher albuminuria and ACR were associated with increased ECV and native T1-time, indicating greater myocardial fibrosis.
- These associations were more pronounced in men, prediabetics, and diabetics.
- No significant association was found between albuminuria/ACR and myocardial scar.
Conclusions:
- Elevated albuminuria is linked to subclinical myocardial fibrosis in a community setting, independent of traditional cardiovascular risk factors.
- The association between albuminuria and myocardial fibrosis is more prominent in males, prediabetics, and diabetics.
Introduction:
Albuminuria is a significant marker for cardiovascular disease(CVD) in both diabetics and non-diabetics. However, its relationship with myocardial fibrosis in the general population remains unclear.
Methods:
The study included 2,112 participants (52%female, mean age69±9years) from the MESA cohort who had urine albumin and creatinine measurements and underwent CMR with T1-mapping for myocardial fibrosis evaluation in 2010. Analyses were stratified by sex and diabetes stage. Multivariable linear and logistic regression models assessed associations of albuminuria/albumin-creatinine ratio(ACR) with extracellular volume (ECV), native T1-time, and myocardial scar.
Results:
In fully adjusted models, a one-SD increase in log-transformed albumin and ACR was associated with 0.15% and 0.2% higher ECV and 2.7% and 2.6% higher native T1 time, respectively. In men, a one-SD increase in log-transformed albumin and ACR was associated with greater ECV (0.3% each) and higher native T1 time (3.3% and 2.6%, respectively). Among women, no significant associations with albuminuria or ACR were found. In participants with prediabetes, log-transformed urine albumin and ACR were positively associated with ECV (p < 0.05) but not with native T1. In diabetics, ACR showed a modest association with ECV and native T1, while log-transformed albumin was significantly associated with 0.3% greater ECV and 3% higher native T1 (p<0.05). The odds of myocardial scar were not associated with higher albumin/ACR after adjusting for CV risk factors.
Conclusions:
Elevated albuminuria levels are related to subclinical fibrosis in a community-based setting, independent of traditional CV risk factors. This association was more prominent among prediabetics, diabetics and among males.
Related Concept Videos
Myocarditis I: Introduction
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure II: Pathophysiology
